adamantane has been researched along with neuropeptide y in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biollaz, J; Buclin, T; Grouzmann, E | 1 |
Abid, K; Aubert, JF; Brakch, N; De Meester, I; Grouzmann, E; Lassahn, PG; Michalet, S; Rochat, B; Stöcklin, R; Tella, P; Vatansever, B | 1 |
Bourguignon, JJ; Jhamandas, JH; Ma, L; MacTavish, D; Simonin, F; Watanabe, T | 1 |
Cavadas, C; Cortez, V; Estrada, M; Grouzmann, E; Marques, AP; Rosmaninho-Salgado, J; Santana, M | 1 |
Bentley, P; Burkey, B; Busch, S; Chibout, SD; Dubost, V; Flavahan, N; Hayes, M; Hoffmann, P; Kaushik, V; Lapadula, D; Longo, L; Martin, L; Moulin, P; Pantano, S; Sahota, P; Schoenfeld, H; Spaet, R; Zhou, W | 1 |
Baines, CP; Burnett, JC; Chakir, K; Cruz Rivera, N; Domeier, TL; Dozier, DG; Emter, CA; Ferguson, BS; Gutiérrez-Aguilar, M; Heublein, DM; Hiemstra, JA; Ivey, JR; Krenz, M; Lee, DI; Marshall, KD; McDonald, KS; Minervini, G; Scherf, C; Zgoda, PJ | 1 |
Cavadas, C; Cunha-Santos, J; Leal, H; Marques, AP; Pereira de Almeida, L; Rosmaninho-Salgado, J; Sousa-Ferreira, L | 1 |
7 other study(ies) available for adamantane and neuropeptide y
Article | Year |
---|---|
Gliptins.
Topics: Adamantane; Adenosine Deaminase; Adenosine Deaminase Inhibitors; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Glycoproteins; Humans; Neuropeptide Y; Nitriles; Pyrrolidines; Vildagliptin | 2007 |
Kinetic study of neuropeptide Y (NPY) proteolysis in blood and identification of NPY3-35: a new peptide generated by plasma kallikrein.
Topics: Adamantane; Adult; Chromatography, Liquid; Female; Humans; Kinetics; Male; Mass Spectrometry; Neuropeptide Y; Nitriles; Peptide Fragments; Peptides; Plasma Kallikrein; Protease Inhibitors; Protein Structure, Tertiary; Pyrrolidines; Substrate Specificity; Vildagliptin | 2009 |
Prolactin-releasing peptide effects in the rat brain are mediated through the Neuropeptide FF receptor.
Topics: Adamantane; Animals; Blood Pressure; Dipeptides; Drug Interactions; gamma-Aminobutyric Acid; Heart Rate; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Injections, Intraventricular; Male; Mutation; Neurons; Neuropeptide Y; Paraventricular Hypothalamic Nucleus; Patch-Clamp Techniques; Prolactin-Releasing Hormone; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Rats, Transgenic; Receptors, G-Protein-Coupled; Receptors, Neuropeptide | 2009 |
Dipeptidyl-peptidase-IV by cleaving neuropeptide Y induces lipid accumulation and PPAR-γ expression.
Topics: 3T3-L1 Cells; Adamantane; Adipocytes; Animals; Cell Differentiation; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Gene Expression; Insulin; Lipid Metabolism; Mice; Neuropeptide Y; Nitriles; PPAR gamma; Proteolysis; Pyrrolidines; Receptors, Neuropeptide Y; Vildagliptin | 2012 |
Vascular origin of vildagliptin-induced skin effects in Cynomolgus monkeys: pathomechanistic role of peripheral sympathetic system and neuropeptide Y.
Topics: Adamantane; Administration, Oral; Animals; Blood Pressure; Cold Temperature; Dipeptidases; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Macaca fascicularis; Neuropeptide Y; Nitriles; Norepinephrine; Pyrrolidines; Skin; Skin Diseases; Stress, Physiological; Vascular System Injuries; Vasoconstriction; Vildagliptin | 2014 |
Saxagliptin and Tadalafil Differentially Alter Cyclic Guanosine Monophosphate (cGMP) Signaling and Left Ventricular Function in Aortic-Banded Mini-Swine.
Topics: Adamantane; Animals; Atrial Natriuretic Factor; Cyclic GMP; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Echocardiography; Hypertrophy, Left Ventricular; Male; Natriuretic Peptide, Brain; Neuropeptide Y; Phosphodiesterase 5 Inhibitors; Signal Transduction; Swine; Swine, Miniature; Tadalafil; Ventricular Function, Left | 2016 |
Dipeptidyl peptidase IV (DPP-IV) inhibition prevents fibrosis in adipose tissue of obese mice.
Topics: 3T3-L1 Cells; Adamantane; Adipocytes; Adipose Tissue, White; Animals; Blood Glucose; Collagen; Diet, High-Fat; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Extracellular Matrix; Fibrosis; Hypolipidemic Agents; Leptin; Lipids; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Neuropeptide Y; Nitriles; Obesity; Pyrrolidines; Receptors, Neuropeptide Y; RNA Interference; RNA, Small Interfering; Transforming Growth Factor beta1; Vildagliptin | 2018 |